U.S. Consumers Overpay for Generic Drugs – USC Schaeffer
COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process - 06/02/2020 | FDA
Pharmaceutical Manufacturing: Current Trends and What's Next | AIChE
Pharmaceutical Manufacturing - an overview | ScienceDirect Topics
Drug Manufacturers Still in Quest for Coronavirus Drugs and Vaccines: Experts at Infiniti Research Reveal How their New Drug Development Strategy Can Help Combat Coronavirus Drug Development Challenges | Business Wire
Recent Developments in Drug Shortages : February 2018 - Pharmacy Purchasing & Products Magazine
Bringing drug production back to the US
Quality by design in pharmaceutical manufacturing: A systematic review of current status, challenges and future perspectives - ScienceDirect
Restoring the Balance Between Innovation and Generic Manufacturing of Medicines Robert M. Goldberg April 2019 Introduction Nearl
Quality and Efficiency in Pharma Manufacturing | CHEManager
Opinion | Americans Need Generic Drugs. But Can They Trust Them? - The New York Times
It's time to bring generic drug manufacturing back to the U.S. - STAT
The top 10 generic drug makers by 2021 revenue
Generic Drug Trends-What's Next?
Government regulated or negotiated drug prices: Key design considerations
U.S. Consumers Overpay for Generic Drugs – USC Schaeffer
Fundamentals of the Pharmaceutical Supply Chain
Generic Drugs
COVID-19 is reshaping the pharmaceutical supply chain
Short and long term impacts of COVID-19 on the pharmaceutical sector | SpringerLink
Update on the US Generic Drug Industry - Opportunities and Challenges_Page_27 - Pharma CI Conference USA
Quality and Efficiency in Pharma Manufacturing | CHEManager
Patents and the Pharmaceutical Industry | California Management Review
Generic drug safety: US regulators struggle to keep up with a global market - Pharmaceutical Technology
'Bottle Of Lies' Exposes The Dark Side Of The Generic-Drug Boom
Mylan's generic drug development illustrates challenges of industry | TribLIVE.com
